Overview

Seizure Activity in Alzheimer's Disease

Status:
Completed
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
The main purpose of this research project is to study how seizure-like activity affects the blood flow in the brain of patients with Alzheimer's disease (AD). Changes in blood flow can change memory and thinking ability, as happens in Alzheimer's disease. The investigators are using a study drug called Levetiracetam, which helps control seizure-like activity to see if it can help change the abnormal blood flow in the brain that is seen in some people with Alzheimer's disease.
Phase:
N/A
Details
Lead Sponsor:
Beth Israel Deaconess Medical Center
Treatments:
Etiracetam
Levetiracetam
Piracetam